Anti-Interleukin-12/23-Antikörper bei Colitis ulcerosa

被引：0
|
作者：
Manfred Gross
机构：
[1] Internistische Klinik München Süd,
来源：
Gastro-News | 2020年 / 7卷 / 2期
关键词：
D O I：
10.1007/s15036-020-0275-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：18 / 21
页数：3
相关论文
共 50 条
  • [31] Anti-interleukin-12 antibody treatment for Crohn disease: Potential risk of invasive disease due to mycobacteria and salmonellae infection
    MacLennan, C
    Lammas, DA
    Kumararatne, DS
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) : 1381 - 1382
  • [32] Predicting response to anti-interleukin 12/23 treatment in psoriasis
    Wu, K. C. P.
    Reynolds, N. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (02) : 240 - 241
  • [33] Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis
    Zisman, DA
    Kunkel, SL
    Strieter, RM
    Gauldie, J
    Tsai, WC
    Bramson, J
    Wilkowski, JM
    Bucknell, KA
    Standiford, TJ
    SHOCK, 1997, 8 (05): : 349 - 356
  • [34] Schwerer Verlauf einer Miliartuberkulose bei einem 34-jährigen Patienten mit Colitis ulcerosa und HIV-Infektion unter einer TNF-α-Antikörper-TherapieSerious Course of a Miliary Tuberculosis in a 34-Year-Old Patient with Ulcerative Colitis and HIV Infection under Concomitant Therapy with Infliximab
    Jonas Zeitz
    Milo Huber
    Gerhard Rogler
    Medizinische Klinik, 2010, 105 (4) : 314 - 318
  • [35] Mondor Disease in a Patient With Psoriasis Treated With an Anti-Interleukin 12/Interleukin 23 Investigational Drug
    Hirano, Stefanie A.
    Mason, Ashley R.
    Warthan, Molly M.
    Pariser, Robert J.
    ARCHIVES OF DERMATOLOGY, 2010, 146 (09) : 1049 - 1050
  • [36] Der Anti-CD20-Antikörper bei primär kutanen B-Zell-Lymphomen Erste Erfahrungen in der dermatologischen AnwendungErste Erfahrungen in der dermatologischen Anwendung
    S. Gellrich
    J.M. Muche
    K. Pelzer
    H. Audring
    W. Sterry
    Der Hautarzt, 2001, 52 (3): : 205 - 210
  • [37] Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Jaber, Fouad
    Ayyad, Mohammed
    Alsakarneh, Saqr
    Alsharaeh, Tala
    Salahat, Ahmed-Jordan
    Jaber, Mohammad
    Gangwani, Manesh Kumar
    Abboud, Yazan
    Mohamed, Islam
    Ali, Hassam
    Kilani, Yassine
    Farraye, Francis A.
    Hashash, Jana G.
    AMERICAN JOURNAL OF THERAPEUTICS, 2025, 32 (01) : e17 - e29
  • [38] Anti-interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report
    Spagnuolo, Rocco
    Dastoli, Stefano
    Silvestri, Martina
    Cosco, Cristina
    Garieri, Pietro
    Bennardo, Luigi
    Nistico, Steven Paul
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [39] Kutane Ulzerationen bei DermatomyositisFallberichte mit positivem Anti-NXP2/Anti-TIF1-gamma-Antikörper-StatusCutaneous ulceration in dermatomyositisCase reports with positive anti-NXP-2/anti-TIF1-gamma antibody status
    Caroline Wald
    Jan-Christoph Simon
    Regina Treudler
    Die Dermatologie, 2025, 76 (2) : 97 - 100
  • [40] Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease
    Saito, K
    Yagita, H
    Hashimoto, H
    Okumura, K
    Azuma, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) : 3098 - 3106
12345